- Home
- KROS vs STR Comparison
KROS vs STR Comparison
Compare KROS & STR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KROS
- STR
- Stock Information
- Founded
- KROS 2015
- STR 2016
- Country
- KROS United States
- STR United States
- Employees
- KROS N/A
- STR N/A
- Industry
- KROS Biotechnology: Pharmaceutical Preparations
- STR Oil & Gas Production
- Sector
- KROS Health Care
- STR Energy
- Exchange
- KROS Nasdaq
- STR Nasdaq
- Market Cap
- KROS 1.8B
- STR 1.7B
- IPO Year
- KROS 2020
- STR N/A
- Fundamental
- Price
- KROS $56.62
- STR $23.42
- Analyst Decision
- KROS Strong Buy
- STR Buy
- Analyst Count
- KROS 8
- STR 6
- Target Price
- KROS $91.43
- STR $29.20
- AVG Volume (30 Days)
- KROS 383.1K
- STR 840.6K
- Earning Date
- KROS 11-06-2024
- STR 11-06-2024
- Dividend Yield
- KROS N/A
- STR 7.29%
- EPS Growth
- KROS N/A
- STR N/A
- EPS
- KROS N/A
- STR N/A
- Revenue
- KROS $651,000.00
- STR $618,668,000.00
- Revenue This Year
- KROS $1,232.45
- STR $6.85
- Revenue Next Year
- KROS $126.39
- STR N/A
- P/E Ratio
- KROS N/A
- STR N/A
- Revenue Growth
- KROS 8037.50
- STR 13.74
- 52 Week Low
- KROS $27.31
- STR $19.88
- 52 Week High
- KROS $73.00
- STR $25.95
- Technical
- Relative Strength Index (RSI)
- KROS 38.94
- STR 58.77
- Support Level
- KROS $65.54
- STR $23.46
- Resistance Level
- KROS $70.26
- STR $25.52
- Average True Range (ATR)
- KROS 3.17
- STR 0.66
- MACD
- KROS -0.64
- STR 0.07
- Stochastic Oscillator
- KROS 9.07
- STR 58.02
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About STR Sitio Royalties Corp.
Sitio Royalties Corp is a pure-play mineral and royalty company. The group focuses on investing in mineral and royalty interests in the Permian and other productive U.S. oil basins.